|
| 36099951 | Exposure to secondhand aerosol from electronic cigarettes at homes: A real-life study in four European countries. | Sci Total Environ | 2023 |
| 37507276 | Evolution of Lung Function in Pregnant Women With Cystic Fibrosis. | Arch Bronconeumol | 2023 |
| 37500327 | Tobacco Patterns and Risk of Chronic Obstructive Pulmonary Disease: Results From a Cross-Sectional Study. | Arch Bronconeumol | 2023 |
| 37394353 | Impact of the COVID-19 pandemic in mortality due to respiratory diseases: A comparative analysis of 2021 and 2020 vs 2019 in Spain. | Med Clin (Barc) | 2023 |
| 37025690 | Sleep apnea-COPD overlap syndrome is associated with larger left carotid atherosclerotic plaques. | Front Cardiovasc Med | 2023 |
| 37267401 | ABO blood group as a determinant of COVID-19 and Long COVID: An observational, longitudinal, large study. | PLoS One | 2023 |
| 37163179 | The ATLAS ASMA Study: Assessing the Impact of Asthma on Patients' Life - The Spanish Patients' Perspective. | J Asthma Allergy | 2023 |
| 36589696 | Genitourinary tract symptoms in patients admitted with COVID-19: Exploring changes in frequency by determinants and pandemic waves. | Continence (Amst) | 2023 |
| 36549937 | Trends of COPD in Spain: Changes Between Cross Sectional Surveys 1997, 2007 and 2017. | Arch Bronconeumol | 2023 |
| 36814553 | Unravelling young COPD and pre-COPD in the general population. | ERJ Open Res | 2023 |
| 36610693 | Dissociation between physical capacity and daily physical activity in COPD patients. A population-based approach. | Respir Med | 2023 |
| 36909731 | Plitidepsin in adult patients with COVID-19 requiring hospital admission: A long-term follow-up analysis. | Front Cell Infect Microbiol | 2023 |
| 36707127 | Prevalence of reduced lung diffusing capacity and CT scan findings in smokers without airflow limitation: a population-based study. | BMJ Open Respir Res | 2023 |
| 34045108 | Psychological Profile of Patients Diagnosed With Idiopathic Pulmonary Fibrosis. | Arch Bronconeumol | 2022 |
| 37497255 | Face Mask Exemptions, Respiratory Patients, and COVID-19 in Spain. Data From the 2021 ITC EUREST-PLUS Spain Survey. | Open Respir Arch | 2022 |
| 35501221 | The Emergence of COVID-19 as a Cause of Death in 2020 and its Effect on Mortality by Diseases of the Respiratory System in Spain: Trends and Their Determinants Compared to 2019. | Arch Bronconeumol | 2022 |
| 35761956 | A Social Return on Investment Analysis of Improving the Management of Chronic Obstructive Pulmonary Disease Within the Spanish National Healthcare System. | Int J Chron Obstruct Pulmon Dis | 2022 |
| 35811284 | Relevant SARS-CoV-2 viremia is associated with COVID-19 severity: Prospective cohort study and validation cohort. | J Med Virol | 2022 |
| 35654818 | Efficacy of short-course colchicine treatment in hospitalized patients with moderate to severe COVID-19 pneumonia and hyperinflammation: a randomized clinical trial. | Sci Rep | 2022 |
| 36421281 | Longitudinal Study of Therapeutic Adherence in a Cystic Fibrosis Unit: Identifying Potential Factors Associated with Medication Possession Ratio. | Antibiotics (Basel) | 2022 |
| 35971815 | [Translated article] Spanish COPD Guidelines (GesEPOC) 2021 Update. Diagnosis and Treatment of COPD Exacerbation Syndrome. | Arch Bronconeumol | 2022 |
| 36199759 | Prevalence of Chronic Obstructive Pulmonary Disease in an Urban Area. Changes in COPD Ten Years on. | Int J Chron Obstruct Pulmon Dis | 2022 |
| 36382234 | Respiratory symptoms and their determinants in the general Spanish population: changes over 20 years. | ERJ Open Res | 2022 |
| 36381995 | Validation of the Spanish Activity Questionnaire in COPD (SAQ-COPD) in Patients with Chronic Obstructive Pulmonary Disease. | Int J Chron Obstruct Pulmon Dis | 2022 |
| 36009967 | Impact of the SARS-CoV-2 Virus Pandemic on Patients with Bronchiectasis: A Multicenter Study. | Antibiotics (Basel) | 2022 |
| 35012962 | Preclinical and randomized phase I studies of plitidepsin in adults hospitalized with COVID-19. | Life Sci Alliance | 2022 |
| 35280896 | Increased Oxygen Desaturation Time During Sleep Is a Risk Factor for NASH in Patients With Obstructive Sleep Apnea: A Prospective Cohort Study. | Front Med (Lausanne) | 2022 |
| 35248041 | Determinants of blood eosinophil levels in the general population and patients with COPD: a population-based, epidemiological study. | Respir Res | 2022 |
| 35312529 | The ANTES program in COPD: First year. | Arch Bronconeumol | 2022 |
| 35312496 | An Euler Proportional Venn Diagram of Obstructive Lung Disease. | Arch Bronconeumol | 2022 |
| 35035025 | Forecasting COVID-19 Infection Trends and New Hospital Admissions in Spain due to SARS-CoV-2 Variant of Concern Omicron. | Arch Bronconeumol | 2022 |
| 35084258 | Use of N-Acetylcysteine at high doses as an oral treatment for patients hospitalized with COVID-19. | Sci Prog | 2022 |
| 35083324 | Evidence for shared genetic risk factors between lymphangioleiomyomatosis and pulmonary function. | ERJ Open Res | 2022 |
| 35340748 | The Emergence of COVID-19 as a Cause of Death in 2020 and its Effect on Mortality by Diseases of the Respiratory System in Spain: Trends and Their Determinants Compared to 2019. | Arch Bronconeumol | 2022 |
| 34433372 | Efficacy and safety of biological drugs in interstitial lung disease associated with connective tissue diseases. | Expert Opin Drug Saf | 2022 |
| 34539032 | [COVID-19 in Youth and the Fifth Wave]. | Arch Bronconeumol | 2022 |
| 32204954 | COPD in Spain at the Start of a New Decade. | Arch Bronconeumol (Engl Ed) | 2021 |
| 37497068 | MEntA Program Based on Motivational Interview to Improve Adherence to Treatment of Obstructive Sleep Apnea With Continuous Positive Airway Pressure (CPAP): A Randomized Controlled Trial. | Open Respir Arch | 2021 |
| 37496843 | Development and Validation of Patient-Reported Outcome Measures (PROM) and Patient-Reported Experience Measures (PREM) in Home Respiratory Therapies: Oxygen Therapy, CPAP Treatment, Mechanical Ventilation, and Aerosol Therapy. | Open Respir Arch | 2021 |
| 33675254 | Cabbage and COVID-19. | Allergy | 2021 |
| 33887489 | Efficacy and safety of abatacept in interstitial lung disease of rheumatoid arthritis: A systematic literature review. | Autoimmun Rev | 2021 |
| 34703072 | On the new post COVID-19 condition. | Arch Bronconeumol | 2021 |
| 34378323 | Histamine signaling and metabolism identify potential biomarkers and therapies for lymphangioleiomyomatosis. | EMBO Mol Med | 2021 |
| 34575262 | Tumor-Associated Granulomas Preceding a Diagnosis of Thoracic Sarcoidosis: A Retrospective, Single-Center Cohort Study. | J Clin Med | 2021 |
| 34629622 | Biologic Therapy in COVID-19. | Arch Bronconeumol | 2021 |
| 34451916 | Pharmacological Interactions of Nintedanib and Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis in Times of COVID-19 Pandemic. | Pharmaceuticals (Basel) | 2021 |
| 34711718 | Usefulness of the CONUT index upon hospital admission as a potential prognostic indicator of COVID-19 health outcomes. | Chin Med J (Engl) | 2021 |
| 34075384 | Plitidepsin has a positive therapeutic index in adult patients with COVID-19 requiring hospitalization. | medRxiv | 2021 |
| 33958231 | On the New Post COVID-19 Condition. | Arch Bronconeumol (Engl Ed) | 2021 |
| 34312290 | Heterogeneity and Cancer-Related Features in Lymphangioleiomyomatosis Cells and Tissue. | Mol Cancer Res | 2021 |